Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tyme Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Tyme Technologies Enters into Collaboration Agreement with Joseph Ahmed 11
Tyme Technologies Enters into Co-development Agreement with University of California San Francisco 12
Merger 13
Tyme Technologies Merges with Tyme in Reverse Merger Transaction 13
Equity Offering 14
Tyme Technologies Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD23.3 Million 14
Tyme Technologies Raises USD8.2 Million in Private Placement of Shares and Warrants 16
Tyme Technologies Files Shelf Registration with SEC To Raise USD250 Million 17
Tyme Technologies Raises USD3.1 Million in Private Placement of Shares 18
Tyme Technologies Raises USD7 Million in Private Placement of Common Stock 19
Tyme Technologies Inc – Key Competitors 20
Tyme Technologies Inc – Key Employees 21
Tyme Technologies Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Jul 30, 2018: Tyme Technologies Provides Clinical and Corporate Update for Fiscal 1Q 2019 23
Corporate Communications 25
Oct 15, 2018: Tyme Technologies names Michele Korfin as Chief Commercial Officer 25
Sep 18, 2018: Tyme Technologies names Douglas A. Michels as Board Director 26
Feb 21, 2018: Tyme Technologies Appoints Tommy G. Thompson to Board of Directors 27
Sep 14, 2017: Tyme Adds Distinguished Drug Developer, Briggs W. Morrison, M.D. to Advisory Board 28
Aug 09, 2017: Tyme Appoints Dr. Jonathan Eckard as Chief Scientific Affairs Officer 29
Mar 29, 2017: Tyme Technologies Announces Two New Board of Director Appointments — David Carberry and James Biehl 30
Mar 23, 2017: Tyme Appoints Ben Taylor as President and Chief Financial Officer 31
Mar 02, 2017: Tyme Technologies Appoints Healthcare Veteran Paul L. Sturman as Independent Director 32
Product News 33
06/05/2017: Tyme Technologies Presents Positive Interim Clinical Data in Recurrent, Non-Metastatic Prostate Cancer at ASCO 2017 33
05/22/2017: Tyme Technologies to Present New Clinical Data for Investigational Drug Candidate SM-88 at 2017 ASCO Annual Meeting 34
01/06/2017: Tyme Technologies Announces Hiring of Shabnam Stanicky as Clinical Operations Officer 35
01/05/2017: Tyme Technologies Advances SM-88 into the Second Stage of its Phase Ib/II Prostate Cancer Trial 36
Other Significant Developments 37
Nov 05, 2018: Tyme provides clinical and corporate update for fiscal 2Q 2019 37
Apr 09, 2018: Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018 38
Feb 07, 2018: Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017 39
Nov 08, 2017: Tyme Provides Clinical and Corporate Update for the Fiscal First Half 2017 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tyme Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tyme Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tyme Technologies Enters into Collaboration Agreement with Joseph Ahmed 11
Tyme Technologies Enters into Co-development Agreement with University of California San Francisco 12
Tyme Technologies Merges with Tyme in Reverse Merger Transaction 13
Tyme Technologies Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD23.3 Million 14
Tyme Technologies Raises USD8.2 Million in Private Placement of Shares and Warrants 16
Tyme Technologies Files Shelf Registration with SEC To Raise USD250 Million 17
Tyme Technologies Raises USD3.1 Million in Private Placement of Shares 18
Tyme Technologies Raises USD7 Million in Private Placement of Common Stock 19
Tyme Technologies Inc, Key Competitors 20
Tyme Technologies Inc, Key Employees 21
List of Figures
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tyme Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9